Ractigen Therapeutics, a clinical-stage biopharmaceutical company pioneering small activating RNA (saRNA) therapeutics, today announced the presentation of positive preliminary data from its ongoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback